References
- Alexander SR, Honda M. Continuous peritoneal dialysis for children: a decade of worldwide growth and development. Kidney Int. 1993; 43: S65–S74, (Suppl 40)
- Khanna R. Dialysis considerations for diabetic patients. Kidney Int. 1993; 43: S58–S64, (Suppl 40)
- Wizemann V, Timio M, Alpert MA, Kramer W. Options in dialysis therapy: significance of cardiovascular findings. Kidney Int. 1993; 43: S85–S91, (Suppl 40)
- Churchill DN. Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients. Kidney Int. 1993; 43: S16–S22, (Suppl 40)
- Korbet SM. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis. Kidney Int. 1993; 43: S111–S119, (Suppl 40)
- Nolph KD. Access problems plague both peritoneal dialysis and hemodialysis. Kidney Int. 1993; 43: S81–S84, (Suppl 40)
- Piraino B, Bernardini J, Sorkin MI. The effect of the Y-set on catheter infection rates in CAPD patients. Am J Kidney Dis. 1990; 16: 46–50
- Registratie Nierfuntievervanging Nederland. Statistisch verslag. Stichting Renine, Rotterdam, The Netherlands 1992
- Moncrief JW, Popovich RP. Continuous ambulatory peritoneal dialysis (CAPD). Peritoneal Dialysis 3d ed., KD Nolph. Kluwer Academic, DordrechtThe Netherlands 1988; 152–168
- Piraino B, Bernardini I, Sorkin M. The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1986; 8: 436–440
- Scalamogna A, Castelnovo C, De Vecchi A, Ponticelli C. Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 1991; 18: 674–677
- Ludlam HA. Infectious consequences of continuous ambulatory peritoneal dialysis. J Hosp Infect. 1991; 18: 341–354, (suppl A)
- Dryden MS, Ludlam HA, Wing AJ, Philips I. Active intervention dramatically reduces CAPD-associated infection. Adv Perit Dial. 1991; 7: 125–128
- Howard RL, Millspaugh J, Teitelbaum I. Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis. Am J Kidney Dis. 1990; 16: 469–472
- Gloor HJ, Nichols WK, Sorkin MI. Peritoneal access and related complications in continuous ambulatory peritoneal dialysis. Am J Med. 1983; 74: 593–598
- Smith WGJ, Tsakiris DJ, Junor BJR. Peritonitis in continuous ambulatory peritoneal dialysis. Scot Med J. 1986; 31: 85–89
- Swartz RD. Chronic peritoneal dialysis: mechanical and infectious complications. Nephron. 1985; 40: 29–37
- Vogt K, Binswanger U, Buchmann P. Catheter-related complications during continuous ambulatory peritoneal dialysis (CAPD): a retrospective study on sixty-two double-cuff Tenckhoff catheters. Am J Kidney Dis. 1987; 10: 47–51
- Searle M, Raman GV. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis. Clin Nephrol. 1985; 23: 241–244
- Popovich RP, Moncrief JW, Nolph KD. Continuous ambulatory peritoneal dialysis. Ann Intern Med. 1978; 88: 449–456
- Ariza M, Lopez M, Quesada T. Complications of CAPD in children: six years experience in Caracas, Venezuela. Adv Perit Dial. 1991; 7: 269–271
- Bernardini J, Holley JL, Johnston JR. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol. 1991; 36: 29–34
- Maiorca R, Cancarini GC, Brunori G. Morbidity and mortality of CAPD and hemodialysis. Kidney Int. 1993; 43: S4–S15, (Suppl 40)
- Holley JL, Bernardini J, Piraino B. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set. Am J Kidney Dis. 1994; 23: 569–573
- Shah GM, Sabo A, Winer RL. Peritoneal leucocyte response to bacterial peritonitis in patients receiving peritoneal dialysis. Int J Artif Organs. 1990; 13: 44–50
- Knight KR, Polak A, Crump J. Laboratory diagnosis and oral treatment of CAPD peritonitis. Lancet 1982; 1301–1304
- Fenton P. Laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. J Clin Pathol. 1982; 35: 1181–1184
- Tranaeus A, Heimbürger O, Lindholm B. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): diagnostic findings, therapeutic outcome and complications. Perit Dial Int. 1989; 9: 179–190
- Bint AJ. Pharmacokinetics of antibiotics in peritoneal dialysis. J Antimicrob Chemother. 1987; 20: 626–628
- Saklayen MG. CAPD peritonitis: incidence, pathogens, diagnosis, and management. Med Clin N Am. 1990; 74: 997–1010
- Gokal R, Ash SR, Helfrich GB. Peritoneal catheters and exit-site practices: toward optimum peritoneal access. Perit Dial Int. 1993; 13: 29–39
- Feldman DS, von Recum A F. Non-epidermally induced failure modes of percutaneous devices. Biomaterials 1985; 6: 352–356
- Schreuders PD, Salthouse TN, von Recum A F. Normal wound healing compared to healing within porous Dacron implants. J Biomed Mater Res. 1988; 22: 121–135
- Yan JYJ, Cooke FW, Vaskelis PS. Titanium-coated Dacron velour: a study of interfacial connective tissue formation. J Biomed Mater Res. 1989; 23: 171–189
- Jansen JA, van der Waerden JPCM, de Groot K. Development of a new percutaneous access device for implantation in soft tissues. J Biomed Mater Res. 1991; 25: 1535–1545
- Jansen JA, Paquay YGCJ, van der Waerden JPCM. Tissue reaction to soft-tissue anchored percutaneous implants in rabbits. J Biomed Mater Res. 1994; 28: 1047–1054